Predicting Disease Progression in Multiple Sclerosis by using a Combination of Highly Sensitive Single Molecule Array Technology (SIMOA) and Untargeted Metabolomics

Authors

Insha Zahoor, Henry Ford HealthFollow
Jeffrey Waters, Henry Ford HealthFollow
Indrani Datta, Henry Ford HealthFollow
Mirela Cerghet, Henry Ford HealthFollow
Laila M. Poisson, Henry Ford HealthFollow
Ramandeep Rattan, Henry Ford HealthFollow
Shailendra Giri, Henry Ford HealthFollow

Recommended Citation

Zahoor I, Waters J, Datta I, Cerghet M, Poisson L, Rattan R, and Giri S. Predicting Disease Progression in Multiple Sclerosis by using a Combination of Highly Sensitive Single Molecule Array Technology (SIMOA) and Untargeted Metabolomics. Mult Scler 2022; 28(1_SUPPL):43-43.

Document Type

Conference Proceeding

Publication Date

5-2022

Publication Title

Mult Scler

Volume

28

Issue

1 Suppl

First Page

43